Growth and maturity in DTx: Finding Pharma's Place Report
Get the industry view from over 200 bioscience professionals of Digital Therapeutics (DTx)
This report explores the view of 203 industry commercial and R&D professionals working in Pharmaceutical, MedTech and Biotech companies whom Bryter surveyed.
It explores the opportunities in the DTx field, including a focus on who is best placed to drive DTx development and innovation, and what benefits and barriers exist for DTx for companies looking to capitalize on this market.
Fill in the form to receive a copy of the full report direct to your inbox
This report explores the view of 203 industry commercial and R&D professionals working in Pharmaceutical, MedTech and Biotech companies whom Bryter surveyed.
It explores the opportunities in the DTx field, including a focus on who is best placed to drive DTx development and innovation, and what benefits and barriers exist for DTx for companies looking to capitalize on this market.
Fill in the form to receive a copy of the full report direct to your inbox